Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Bliss GVS Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1985 on BSE, Jul 2010 on NSE
Last close ₹647.50down ₹33.40 (4.91%)BSE ₹648.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹680.90.
30 Oct: open ₹660.00, high ₹670.00, low ₹646.90
52-week range of traded prices to 30 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,885 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.71
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.23%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,45,760
Bliss GVS Pharma share news and announcements
628 announcements, routine notices left out, newest first. Page 12 of 13.
Aug 2013
5 Aug · Board meeting
To consider interalia, the Un-audited Financial Results of the Company for the Quarter ended June 30, 2013.
Jul 2013
24 Jul · Meeting
Company has fixed Book Closure from August 5, 2013 to August 9, 2013 (both days inclusive) for the purpose of Declaration of Dividend. Further, the Annual General Meeting of the Company is scheduled to be held on August 14, 2013.
Jun 2013
7 Jun · Corporate action
Company has fixed Book Closure from August 5, 2013 to August 9, 2013 (both days inclusive) for the purpose of dividend.
May 2013
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2013 has approved the following:(1) Renewed the tenure and new salary, terms & conditions, of the Managing Director - Mr. S. N. Kamath and Whole Time Directors - Mrs. Shruti N. Kamath and Mrs. Vibha N. Kamath for a period of three years.29 May · Dividend
Board of Directors of the Company at its meeting held on May 28, 2013 has recommended a dividend of 40% i.e. 0.40 per Equity Share for the year ended March 31, 2013.22 May · Board meeting
To consider interalia, the audited Financial Results of the company for the year ended March 31, 2013 and dividend, if any.
Apr 2013
Feb 2013
14 Feb · Dividend
Board of Directors of the Company at its meeting held on February 13, 2013, inter alia, has declared an Interim Dividend of 30% i.e. Re. 0.30 per equity share for the year 2012-2013.14 Feb · Corporate action
Company has fixed Record Date as February 26, 2013 for the purpose of payment of Interim dividend.6 Feb · Board meeting
To Consider interalia, the un-audited Financial Results of the Company for the Quarter ended December 31, 2012 and Dividend if any.
Nov 2012
1 Nov · Board meeting
To consider, inter alia, the Un-audited Financial Results for the Quarter ended September 30, 2012.
Aug 2012
10 Aug · Change in Company Secretary
Board of Directors of the Company at its meeting held on August 10, 2012: (1) Ms. Jyoti Asawa Resign as a Company Secretary of the Company.(2) Mr. Amarendra Mohapatra appointed as a Company Secretary and Compliance Officer of the Company.10 Aug · Results
8 Aug · Management
Ms. Jyoti Asawa Company Secretary resign from the Company with immediate effect.
Jul 2012
30 Jul · Board meeting
To consider, interalia, the Un-audited Financial Results of the Company for the Quarter ended June 30, 2012.
Jun 2012
28 Jun · Updates
Company has acquired 70% management stake in the company M/s Kremoint Pharma Private Limited. M/s Kremoint Pharma Private Limited is into manufacturing of pharmaceuticals and a leading company in the manufacture and export of Creams, Ointments and Gels. These acquisitions then boast the company's strength in the manufacture and export of pharmaceuticals.25 Jun · Meeting
Annual General Meeting of the Company will be held on August 10, 2012. Further, the Register of Members and the Share Transfer Books of the Company will remain closed from August 06, 2012 to August 10, 2012 (both days inclusive) for the purpose of Declaration of Dividend.1 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2012 has recommended 40% Dividend i.e Rs.0.40 per equity share for the year ended March 31, 2012.
May 2012
19 May · Board meeting
To consider interalia, the Audited Financial Results of the Company for the year ended March 31, 2012 and dividend, if any.
Feb 2012
Jan 2012
30 Jan · Board meeting
To Consider interalia, the un-audited Financial Results of the Company for the Quarter ended December 31, 2011.
Nov 2011
14 Nov · Corporate action
November 25, 2011 has been fixed as the Record Date for the purpose of Payment of Interim Dividend.14 Nov · Dividend
Board of Directors of the Company at its meeting held on November 11, 2011, inter alia, has declared 35% (Re. 0.35) Interim Dividend per share for the year 2011-12.
Oct 2011
31 Oct · Board meeting
To consider, inter alia, the Un-audited Financial Results for the Quarter ended September 30, 2011 and dividend if any.5 Oct · Updates
Company has received an Award from Pharmexcil "Outstanding Export Performance Award in the Recognition of Commendable Contribution to Pharmaceuticals Exports From India for the year 2010-11"
Sep 2011
12 Sep · Updates
Mr. S. N. Kamath Promoter & Managing Director of the Company has received a ; "National Award - 2010 from Government of India In recognition outstanding performance Research & Development under Medium Enterprises".
Jul 2011
29 Jul · Board meeting
Meeting of the Board of the Directors of the Company was held on July 29, 2011 and have approved the following : (1) Appointment of Mr. S. R. Vaidya as Independent Director of the Company; (2) Mr. Ashish Narayan resign as a Company Secretary of the Company; (3) Mrs. Jyoti Ashawa appointed as a Company Secretary of the Company.19 Jul · Board meeting
To consider, inter alia, the Un-audited Financial Results for the Quarter ended June 30, 2011.14 Jul · Purchase of Shares
12 Jul · Purchase of Shares
Jun 2011
9 Jun · Management
Board of Directors of the Company at its meeting held on May 30, 2011 has approved: (1) Appointment of Mr. Mayak Mehta as Independent Director of the Company.1 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2011 has recommended a dividend of 30% i.e. Rs.0.30 per equity share for the year ended March 31, 2011.
May 2011
23 May · Board meeting
To consider, interalia, the Audited Financial Result for the year ended March 31, 2011 and dividend if any.
Apr 2011
25 Apr · Management
Mr. Yogendra N. Thakkar is tended his resignation as an Independent Director of the Company on April 21, 2011 due to his personal reasons.1 Apr · Purchase of Shares
Mar 2011
22 Mar · Management
Mr. Satej M. Katekar is tended his resignation as an Independent Director of the Company on March 21, 2011 due to pre occupation.21 Mar · Purchase of Shares